Endolipid Therapeutics, the spin-off of Vall d’Hebron and GENESIS Ventures, emerges to develop a new strategy to reduce visceral and subcutaneous fat ... 17 June, 2021
The Gregorio Marañón Hospital creates a spin-off to market the drug that protects the kidney ... 10 May, 2021
GENESIS Biomed provides support to different projects in the field of in vitro fertilisation ... 06 May, 2021
